Antiparasitic evaluation of salicylate and salicylamide derivatives
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Health Review |
Texto Completo: | https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/61746 |
Resumo: | In the present study, twelve salicylic acid derivatives were obtained through Fischer esterification, the Mitsunobu reaction, and the acid chloride reactions. The products were structurally characterized using infrared, 1H NMR, 13C NMR spectroscopy, and high resolution mass spectrometry of three unpublished compounds. Then they were evaluated against the parasites Leishmania braziliensis, Trypanosoma cruzi, and Plasmodium falciparum. Some compounds were weakly bioactive against L. braziliensis amastigotes, such as N-cyclohexyl-2-hydroxybenzamide (10), EC50 = 15.60 ± 2.69 µM and SI = 2.67, and against T. cruzi such as 4-methoxybenzyl 2-hydroxybenzoate (8) EC50 > 23.23 µM and SI < 2.41. The compounds did not present significant activity against P. falciparum. The data obtained indicate that salicylic acid derivatives can be structurally modified for the synthesis of more potent and selective compounds against parasites that cause several neglected diseases. |
id |
BJRH-0_3ff4ebb938a8365deee421dda8ef43b9 |
---|---|
oai_identifier_str |
oai:ojs2.ojs.brazilianjournals.com.br:article/61746 |
network_acronym_str |
BJRH-0 |
network_name_str |
Brazilian Journal of Health Review |
repository_id_str |
|
spelling |
Antiparasitic evaluation of salicylate and salicylamide derivativesnatural productssalicylic acidneglected diseasesLeishmaniaTrypanosomaIn the present study, twelve salicylic acid derivatives were obtained through Fischer esterification, the Mitsunobu reaction, and the acid chloride reactions. The products were structurally characterized using infrared, 1H NMR, 13C NMR spectroscopy, and high resolution mass spectrometry of three unpublished compounds. Then they were evaluated against the parasites Leishmania braziliensis, Trypanosoma cruzi, and Plasmodium falciparum. Some compounds were weakly bioactive against L. braziliensis amastigotes, such as N-cyclohexyl-2-hydroxybenzamide (10), EC50 = 15.60 ± 2.69 µM and SI = 2.67, and against T. cruzi such as 4-methoxybenzyl 2-hydroxybenzoate (8) EC50 > 23.23 µM and SI < 2.41. The compounds did not present significant activity against P. falciparum. The data obtained indicate that salicylic acid derivatives can be structurally modified for the synthesis of more potent and selective compounds against parasites that cause several neglected diseases.Brazilian Journals Publicações de Periódicos e Editora Ltda.2023-07-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/6174610.34119/bjhrv6n4-156Brazilian Journal of Health Review; Vol. 6 No. 4 (2023); 15959-15976Brazilian Journal of Health Review; Vol. 6 Núm. 4 (2023); 15959-15976Brazilian Journal of Health Review; v. 6 n. 4 (2023); 15959-159762595-6825reponame:Brazilian Journal of Health Reviewinstname:Federação das Indústrias do Estado do Paraná (FIEP)instacron:BJRHenghttps://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/61746/44487Oliveira, Ana Júlia de Morais SantosPineda, TatianaRobledo, Sara Mariade Sousa, Damião Pergentinoinfo:eu-repo/semantics/openAccess2023-09-04T13:15:42Zoai:ojs2.ojs.brazilianjournals.com.br:article/61746Revistahttp://www.brazilianjournals.com/index.php/BJHR/indexPRIhttps://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/oai|| brazilianjhr@gmail.com2595-68252595-6825opendoar:2023-09-04T13:15:42Brazilian Journal of Health Review - Federação das Indústrias do Estado do Paraná (FIEP)false |
dc.title.none.fl_str_mv |
Antiparasitic evaluation of salicylate and salicylamide derivatives |
title |
Antiparasitic evaluation of salicylate and salicylamide derivatives |
spellingShingle |
Antiparasitic evaluation of salicylate and salicylamide derivatives Oliveira, Ana Júlia de Morais Santos natural products salicylic acid neglected diseases Leishmania Trypanosoma |
title_short |
Antiparasitic evaluation of salicylate and salicylamide derivatives |
title_full |
Antiparasitic evaluation of salicylate and salicylamide derivatives |
title_fullStr |
Antiparasitic evaluation of salicylate and salicylamide derivatives |
title_full_unstemmed |
Antiparasitic evaluation of salicylate and salicylamide derivatives |
title_sort |
Antiparasitic evaluation of salicylate and salicylamide derivatives |
author |
Oliveira, Ana Júlia de Morais Santos |
author_facet |
Oliveira, Ana Júlia de Morais Santos Pineda, Tatiana Robledo, Sara Maria de Sousa, Damião Pergentino |
author_role |
author |
author2 |
Pineda, Tatiana Robledo, Sara Maria de Sousa, Damião Pergentino |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Oliveira, Ana Júlia de Morais Santos Pineda, Tatiana Robledo, Sara Maria de Sousa, Damião Pergentino |
dc.subject.por.fl_str_mv |
natural products salicylic acid neglected diseases Leishmania Trypanosoma |
topic |
natural products salicylic acid neglected diseases Leishmania Trypanosoma |
description |
In the present study, twelve salicylic acid derivatives were obtained through Fischer esterification, the Mitsunobu reaction, and the acid chloride reactions. The products were structurally characterized using infrared, 1H NMR, 13C NMR spectroscopy, and high resolution mass spectrometry of three unpublished compounds. Then they were evaluated against the parasites Leishmania braziliensis, Trypanosoma cruzi, and Plasmodium falciparum. Some compounds were weakly bioactive against L. braziliensis amastigotes, such as N-cyclohexyl-2-hydroxybenzamide (10), EC50 = 15.60 ± 2.69 µM and SI = 2.67, and against T. cruzi such as 4-methoxybenzyl 2-hydroxybenzoate (8) EC50 > 23.23 µM and SI < 2.41. The compounds did not present significant activity against P. falciparum. The data obtained indicate that salicylic acid derivatives can be structurally modified for the synthesis of more potent and selective compounds against parasites that cause several neglected diseases. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-07-27 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/61746 10.34119/bjhrv6n4-156 |
url |
https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/61746 |
identifier_str_mv |
10.34119/bjhrv6n4-156 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/61746/44487 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Brazilian Journals Publicações de Periódicos e Editora Ltda. |
publisher.none.fl_str_mv |
Brazilian Journals Publicações de Periódicos e Editora Ltda. |
dc.source.none.fl_str_mv |
Brazilian Journal of Health Review; Vol. 6 No. 4 (2023); 15959-15976 Brazilian Journal of Health Review; Vol. 6 Núm. 4 (2023); 15959-15976 Brazilian Journal of Health Review; v. 6 n. 4 (2023); 15959-15976 2595-6825 reponame:Brazilian Journal of Health Review instname:Federação das Indústrias do Estado do Paraná (FIEP) instacron:BJRH |
instname_str |
Federação das Indústrias do Estado do Paraná (FIEP) |
instacron_str |
BJRH |
institution |
BJRH |
reponame_str |
Brazilian Journal of Health Review |
collection |
Brazilian Journal of Health Review |
repository.name.fl_str_mv |
Brazilian Journal of Health Review - Federação das Indústrias do Estado do Paraná (FIEP) |
repository.mail.fl_str_mv |
|| brazilianjhr@gmail.com |
_version_ |
1797240032329728000 |